Cargando…
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
Dendritic cells (DCs) are the most potent professional antigen presenting cells and are therefore indispensable for the control of immunity. The technique of antibody mediated antigen targeting to DC subsets has been the basis of intense research for more than a decade. Many murine studies have util...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931625/ https://www.ncbi.nlm.nih.gov/pubmed/27043640 http://dx.doi.org/10.3390/vaccines4020008 |
_version_ | 1782440932282466304 |
---|---|
author | Lehmann, Christian H. K. Heger, Lukas Heidkamp, Gordon F. Baranska, Anna Lühr, Jennifer J. Hoffmann, Alana Dudziak, Diana |
author_facet | Lehmann, Christian H. K. Heger, Lukas Heidkamp, Gordon F. Baranska, Anna Lühr, Jennifer J. Hoffmann, Alana Dudziak, Diana |
author_sort | Lehmann, Christian H. K. |
collection | PubMed |
description | Dendritic cells (DCs) are the most potent professional antigen presenting cells and are therefore indispensable for the control of immunity. The technique of antibody mediated antigen targeting to DC subsets has been the basis of intense research for more than a decade. Many murine studies have utilized this approach of antigen delivery to various kinds of endocytic receptors of DCs both in vitro and in vivo. Today, it is widely accepted that different DC subsets are important for the induction of select immune responses. Nevertheless, many questions still remain to be answered, such as the actual influence of the targeted receptor on the initiation of the immune response to the delivered antigen. Further efforts to better understand the induction of antigen-specific immune responses will support the transfer of this knowledge into novel treatment strategies for human diseases. In this review, we will discuss the state-of-the-art aspects of the basic principles of antibody mediated antigen targeting approaches. A table will also provide a broad overview of the latest studies using antigen targeting including addressed DC subset, targeted receptors, outcome, and applied coupling techniques. |
format | Online Article Text |
id | pubmed-4931625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-49316252016-07-08 Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies Lehmann, Christian H. K. Heger, Lukas Heidkamp, Gordon F. Baranska, Anna Lühr, Jennifer J. Hoffmann, Alana Dudziak, Diana Vaccines (Basel) Review Dendritic cells (DCs) are the most potent professional antigen presenting cells and are therefore indispensable for the control of immunity. The technique of antibody mediated antigen targeting to DC subsets has been the basis of intense research for more than a decade. Many murine studies have utilized this approach of antigen delivery to various kinds of endocytic receptors of DCs both in vitro and in vivo. Today, it is widely accepted that different DC subsets are important for the induction of select immune responses. Nevertheless, many questions still remain to be answered, such as the actual influence of the targeted receptor on the initiation of the immune response to the delivered antigen. Further efforts to better understand the induction of antigen-specific immune responses will support the transfer of this knowledge into novel treatment strategies for human diseases. In this review, we will discuss the state-of-the-art aspects of the basic principles of antibody mediated antigen targeting approaches. A table will also provide a broad overview of the latest studies using antigen targeting including addressed DC subset, targeted receptors, outcome, and applied coupling techniques. MDPI 2016-03-28 /pmc/articles/PMC4931625/ /pubmed/27043640 http://dx.doi.org/10.3390/vaccines4020008 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Lehmann, Christian H. K. Heger, Lukas Heidkamp, Gordon F. Baranska, Anna Lühr, Jennifer J. Hoffmann, Alana Dudziak, Diana Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies |
title | Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies |
title_full | Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies |
title_fullStr | Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies |
title_full_unstemmed | Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies |
title_short | Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies |
title_sort | direct delivery of antigens to dendritic cells via antibodies specific for endocytic receptors as a promising strategy for future therapies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931625/ https://www.ncbi.nlm.nih.gov/pubmed/27043640 http://dx.doi.org/10.3390/vaccines4020008 |
work_keys_str_mv | AT lehmannchristianhk directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies AT hegerlukas directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies AT heidkampgordonf directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies AT baranskaanna directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies AT luhrjenniferj directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies AT hoffmannalana directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies AT dudziakdiana directdeliveryofantigenstodendriticcellsviaantibodiesspecificforendocyticreceptorsasapromisingstrategyforfuturetherapies |